Collectively, these results showing the reduction in tumor hypoxia and enhanced vascular flow when S1P is neutralized support the notion that a transient “vascular normalization” [41] is the mechanism by which anti-S1P mAb exerts its effects, an effect which could enhance the efficacy of cytotoxic agents (see below). Here, MBTPS1 is linked to neoplasm.